Table 3.
No IMNI | IMNI | P value | |
---|---|---|---|
Patterns of failure in the unadjusted cohort | |||
Local | 2 (0.8%) | 2 (1.9%) | 0.385 |
Regional | 14 (5.8%) | 2 (1.9%) | 0.115 |
Axilla | 4 | 0 | |
SCN | 2 | 2 | |
IMN | 4 | 0 | |
Axilla & SCN | 3 | 0 | |
SCN & IMN | 1 | 0 | |
DM | 51 (21.0%) | 10 (9.5%) | 0.010 |
LRR only | 2 (0.8%) | 1 (1.0%) | 0.082 |
DM only | 39 (16.0%) | 8 (7.6%) | |
LRR + DM | 12 (4.9%) | 2 (1.9%) | |
Death | 31 (12.8%) | 3 (2.9%) | 0.004 |
Death without disease | 2 | 0 | |
Patterns of failure in the inverse probability treatment weighting-adjusted cohort | |||
Local | 2.0 (0.8%) | 3.4 (2.3%) | 0.254 |
Regional | 14.7 (5.6%) | 2.1 (1.4%) | 0.035 |
DM | 49.6 (18.8%) | 16.2 (11.1%) | 0.034 |
IMNI, internal mammary node irradiation; SCN, supraclavicular node; IMN, internal mamary node; LRR, locoregional recurrence; DM, distant metastasis.